From a comparison of dermal indexes in these studies, the contribution of maternal mosaicism to all cases of Down's syndrome is estimated to be about 11% and the contribution of paternal mosaicism about 8%. The contribution from mosaicism in the father but not in the mother appears to increase with parental age. To confirm these estimates, more parents with trisomy 21 mosaicism and trisomy 21 offspring must be diagnosed and studied quantitatively for dermal microsymptoms.
Summary. Fathers and mothers of Down's syndrome cases show dermal microsymptoms when a large series of parents are compared to the general population. A Walker dermal index score in the overlap range (-2 99 to + 3 '00) is more likely to occur in fathers of age-dependent Down's syndrome cases (mean paternal age 40, range 25 to 54 years) and in Down's syndrome mothers than in the general population. The relative risk for these fathers to have a dermal index in the overlap range is two times the risk for male controls; the corresponding risk for mothers of Down's syndrome cases is 1'6 times that for female controls. Thus a score in the overlap range may be used to indicate a group of parents at higher risk for recurrence and occurrence of trisomy 21 offspring. This higher risk parent group can be offered cytogenetic studies, including amniocentesis and chromosome analysis on peripheral blood and skin, as dictated by clinical circumstances.
From a comparison of dermal indexes in these studies, the contribution of maternal mosaicism to all cases of Down's syndrome is estimated to be about 11% and the contribution of paternal mosaicism about 8%. The contribution from mosaicism in the father but not in the mother appears to increase with parental age. To confirm these estimates, more parents with trisomy 21 mosaicism and trisomy 21 offspring must be diagnosed and studied quantitatively for dermal microsymptoms.
In a previous study (Priest, 1969) 
328
The control group of 204 were clinically normal, unrelated individuals from families without known chromosomal defect.
Both ink* and inklesst printing materials were used to print fingers, palms, and feet. The Walker index (1958) previously published (Priest, 1969 ) is a significant difference between male and female controls; thus statistical comparisons of mean dermal indexes between control and parent groups are matched for sex in this report. A one-tail probability figure is acceptable in this analysis because of our initial hypothesis that parents tend, on the average, to resemble their Down's syndrome offspring dermatoglyphically. Therefore, the patients' dermal indexes cannot be either more positive or more negative than controls but can vary only in one direction. Table III) . Table IV summarizes the number of individuals in two MA groups (less than 35 years and 35 years or more) with dermal indexes in the overlap range (-299 to + 3 00). Controls and Down's syndrome parents are compared and significance of differences analysed by the Fisher exact probability test (Siegal, 1956) . Chi-square analysis gave similar results; however, Fisher's test is the method of choice here because it provides exact probabilities while chisquare analysis provides only an estimate of probabilities. The number of individuals with scores in the overlap range are significantly higher for the following (1) fathers in the old MA group compared to male controls; (2) all mothers compared to all controls and compared to female controls; (3) young mothers (MA less than 35) compared to all controls and female controls. There was no significant difference between male and female controls.
In Table V the five sets from Table IV showing Table I ). The average paternal age in this group is 40 years (range 25 to 54 years). Mothers of relatively age-independent Down's cases also show dermal microsymptoms (MA less than 34 years, average MA 25 years, range 15-34 years). This latter effect is most striking in the MA group 25 to 34 years rather than in the youngest MA group of 15 to 24 years (see Table III ); however, differences in parental dermal indexes between the various MA groups by 10-year intervals are not significant. Penrose and Smith (1966) postulated that trisomy in the mother might tend to reduce fertility by shortening the reproductive period. In seven affected children of five mosaic mothers, the average maternal age was reported to be 22-7 years; thus, there was no indication of increased maternal age. We also find more dermal microsymptoms in younger mothers rather than in the mothers aged 35 (Penrose and Smith, 1966) .
There is still no proof that dermal microsymptoms represent mosaicism for trisomy 21 although Sachs (1971) In the meantime, these studies show that the chance for a Walker score in the overlap range (-2 99 to + 3-00) is significantly increased for fathers in the maternal age-dependent group (mean paternal age 40, range 25 to 54) and for mothers of Down's syndrome offspring (see Table IV ). The risk for this group of fathers is two times the risk for male controls and the risk for mothers is 1 6 times the risk for female controls (see Table V ). It is suggested that a score in the overlap range can be used to indicate increased risk for recurrence of trisomic children and probably can be used to screen parents at risk for occurrence of trisomic offspring. Such parents could be offered amniocentesis or cytogenetic evaluation for trisomy 21 mosaicism in skin or peripheral blood, as dictated by clinical circumstances.
